Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

28 trials with published results (25%)

Research Maturity

88 completed trials (79% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.5%

5 terminated out of 111 trials

Success Rate

94.6%

+8.1% vs benchmark

Late-Stage Pipeline

23%

25 trials in Phase 3/4

Results Transparency

32%

28 of 88 completed with results

Key Signals

28 with results95% success

Data Visualizations

Phase Distribution

92Total
Not Applicable (10)
Early P 1 (1)
P 1 (27)
P 2 (29)
P 3 (16)
P 4 (9)

Trial Status

Completed88
Unknown9
Terminated5
Active Not Recruiting3
Withdrawn3
Enrolling By Invitation1

Trial Success Rate

94.6%

Benchmark: 86.5%

Based on 88 completed trials

Clinical Trials (111)

Showing 20 of 20 trials
NCT05797246Phase 2Active Not Recruiting

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

NCT07393685Not Yet Recruiting

Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD

NCT04382131Not ApplicableTerminated

Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)

NCT04124198Not ApplicableActive Not Recruiting

Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma

NCT04769167Not ApplicableCompleted

Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes

NCT06366672Early Phase 1Active Not Recruiting

Evaluating the Human Immune Response to the JYNNEOS Vaccine

NCT06149494Phase 2Completed

RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection

NCT06779175Completed

Analysis of Single Respiratory Viral Infections Versus Co-infections: Prevalence and ICU Needs in Hospitalized Adults

NCT05284097Phase 2CompletedPrimary

Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

NCT04772469Not ApplicableCompleted

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

NCT05875961Phase 1Completed

Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults

NCT04441047Phase 1CompletedPrimary

Universal Anti-Viral Vaccine for Healthy Elderly Adults

NCT05874713Phase 2Completed

Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults

NCT04633603Enrolling By Invitation

LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System

NCT03487549Phase 2Completed

Cantharidin and Occlusion in Verruca Epithelium

NCT05074953CompletedPrimary

Post-COVID-19 Monitoring in Routine Health Insurance Data

NCT02545517Phase 3CompletedPrimary

A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.

NCT04380701Phase 1Completed

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

NCT06113757Not ApplicableCompleted

Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease

NCT04476979Phase 2Completed

Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19

Scroll to load more

Research Network

Activity Timeline